What you need to know about how new EMA rules affect patient participation in scientific assessments
As of 1 May 2025, new rules at the European Medicines Agency (EMA) are into force and refine how patients and representatives can participate as experts...
PRESS RELEASE - World Asthma Day 2025: European patients call for urgent action to close gaps in asthma care
Brussels, 6 May 2025 – The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) marks World Asthma Day with a patient community-led...
12 EU Member States demand immediate action on tobacco legislation delays
Twelve EU Member States have formally called on the European Commission to urgently revise Europe’s key tobacco legislation, highlighting significant...
Bringing patients’ need to the centre of Europe's Life Sciences Strategy
Every day, 200 million people live with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe. For them, advances in science are...
EU health data regulation enters into force: unlocking access to health records for patients
On 26 March 2025, the European Health Data Space (EHDS) Regulation officially became EU law. This is a major step forward for building a European Health...
EFA launches Community support scheme for World Atopic Eczema Day 2025 projects
For the second year, EFA has launched a Community support scheme to support EFA members projects to raise national and local awareness in the lead up to...
EFA Community convenes at the 2025 Annual General Meeting and Community Meeting in Slovenia
From 24 to 26 March, EFA Community gathered in Ljubljana, Slovenia, hosted by our member Društvo Atopijski Dermatitis, for EFA’s Annual General Meeting...
EFA advocates for patient safety first in the review of the medical device regulation
On 21 March, the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) submitted its response to the European Commission’s...
EU proposal for a Critical Medicines Act to address shortages – EFA perspective
On 27 February, the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) submitted its input to the European Commission’s...
EFA mobilises for the adoption of World Resolution on Skin Diseases
Together with patient organisations around the world and our members across Europe, EFA is mobilising our atopic eczema and skin allergy communities...
38 experts join forces to improve lung health for youth: the #LungHealth4Life Community of Practice kicks off
On 25 February 2025, EFA hosted the first online meeting of the LungHealth4Life Community of Practice (CoP). The event marked the beginning of a collaborative...
European Commission prioritises competitiveness, as prevention retreats – EFA perspective on the 2025 Work Programme
On 11 February, the European Commission presented its annual Work Programme for 2025, setting the legislative agenda for the year ahead. This is the first...
EFA Community illustrates why EU Member States should implement the new Air Quality Directive
For most people, breathing is effortless. Yet for millions of Europeans with allergy, asthma, chronic obstructive pulmonary disease (COPD) and severe allergy,...
Why indoor air quality must be a European priority
We spend 90% of our time indoors, yet indoor air quality (IAQ) remains overlooked in EU policymaking. For millions of people with allergy and respiratory...
Shaping the future of COPD care in Europe: a call for urgent action at the European Parliament
The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) recently brought together at the European Parliament patient advocates,...
EFA welcomes EMA plan to draft guidelines on nasal spray treatments
EFA responded to the European Medicines Agency's (EMA) consultation on a concept note to develop new guidelines aimed at ensuring therapeutic equivalence...
A new era for patient access to care in Europe: the EU HTA Regulation enters into force
On January 12, 2025, the Health Technology Assessment Regulation (HTAR) officially came into force, marking a significant milestone in European healthcare,...
Protecting students with food allergies: EFA and GA2LEN publish joint action plan on anaphylaxis management in schools
For children and youth with food allergies, the classroom is not just a place for learning, but also a space where careful precautions are essential to...
The EU expands the list of critical medicines: what is in it for allergy, atopic eczema, asthma and COPD care?
On the 16th of December, the European Medicines Agency (EMA) published the updated version of the critical medicines list (CML), marking a significant...
Is the EU better prepared for a pandemic? EFA’s evaluation of the EU serious cross-border threats to health regulation
While COVID-19 was hitting hard the world in March 2020, the European Union started reviewing its legal tools and financial instruments to address health...